BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guns LA, Monteagudo S, Kvasnytsia M, Kerckhofs G, Vandooren J, Opdenakker G, Lories RJ, Cailotto F. Suramin increases cartilage proteoglycan accumulation in vitro and protects against joint damage triggered by papain injection in mouse knees in vivo. RMD Open 2017;3:e000604. [PMID: 29299344 DOI: 10.1136/rmdopen-2017-000604] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Cornelis FMF, Lories RJ, Monteagudo S. Exostosin-1 enhances canonical Wnt signaling activity during chondrogenic differentiation. Osteoarthritis Cartilage 2019;27:1702-10. [PMID: 31330188 DOI: 10.1016/j.joca.2019.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
2 Liu ZM, Lu CC, Shen PC, Chou SH, Shih CL, Chen JC, Tien YC. Suramin attenuates intervertebral disc degeneration by inhibiting NF-κB signalling pathway. Bone Joint Res 2021;10:498-513. [PMID: 34372688 DOI: 10.1302/2046-3758.108.BJR-2020-0041.R3] [Reference Citation Analysis]
3 Attri A, Thakur D, Kaur T, Sensale S, Peng Z, Kumar D, Singh RP. Nanoparticles Incorporating a Fluorescence Turn-on Reporter for Real-Time Drug Release Monitoring, a Chemoenhancer and a Stealth Agent: Poseidon's Trident against Cancer? Mol Pharm 2021;18:124-47. [PMID: 33346663 DOI: 10.1021/acs.molpharmaceut.0c00730] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 McClurg O, Tinson R, Troeberg L. Targeting Cartilage Degradation in Osteoarthritis. Pharmaceuticals (Basel) 2021;14:126. [PMID: 33562742 DOI: 10.3390/ph14020126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhou Y, Chen X, Qu N, Zhang B, Xia C. Chondroprotection of PPARα activation by WY14643 via autophagy involving Akt and ERK in LPS‐treated mouse chondrocytes and osteoarthritis model. J Cell Mol Med 2019;23:2782-93. [DOI: 10.1111/jcmm.14184] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
6 Min L, Wu Y, Cao G, Mi D, Chen C. A network pharmacology strategy to investigate the anti-osteoarthritis mechanism of main lignans components of Schisandrae Fructus. Int Immunopharmacol 2021;98:107873. [PMID: 34182246 DOI: 10.1016/j.intimp.2021.107873] [Reference Citation Analysis]